Login / Signup

Richter's transformation in patients with chronic lymphocytic leukaemia: a Nationwide Epidemiological Study.

Yasmin Ben-DaliMariam H HleuhelCaspar da Cunha-BangChristian BrieghelChristian B PoulsenErik Clasen-LindeHans H N BentzenHenrik FrederiksenIlse ChristiansenLinda H NielsenLisbeth EnggaardMarie HellebergMichael ClausenMikael FrederiksenRobert S PedersenCarsten U NiemannMichael A Andersen
Published in: Leukemia & lymphoma (2020)
Richter's transformation (RT) refers to the development of an aggressive lymphoma in patients with chronic lymphocytic leukemia (CLL). Approximately, 2-10% of patients with CLL develop RT, most often as diffuse large B-cell lymphoma. To assess the incidence of RT, we examined risk factors for RT and death among patients with RT in a nationwide CLL cohort (from 2008 to 2016). Among 3772 patients, 113 had biopsy-proven RT. With a median follow-up of 4.3 years, the 5-year cumulative incidence of RT was 2.8%. Advanced Binet stage (B/C) (p<.001), unmutated IGHV (p<.001), and del(17p) (p<.001) were independently associated with risk of developing RT. Half of the patients with RT (49%) were treatment-naïve prior to transformation and demonstrated longer survival after RT compared to patients previously treated for CLL (6.1 vs. 2.8 years, p=.03). Whether this finding could be explained by a higher proportion of clonally unrelated RT among treatment-naïve patients, remain to be addressed.
Keyphrases
  • chronic lymphocytic leukemia
  • diffuse large b cell lymphoma
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • risk factors
  • prognostic factors
  • cross sectional
  • cord blood